Visit COVID-19 resources

[Skip to Content]

Eye Journal

Brolucizumab: is extended VEGF suppression on the horizon? – (Eye Journal)

Sep 16
2019

Eye, Published online: 16 September 2019; doi:10.1038/s41433-019-0582-0 Brolucizumab: is extended VEGF suppression on the horizon?

  • 16 September 2019

Oral medications for central serous chorioretinopathy: a literature review – (Eye Journal)

Sep 16
2019

Eye, Published online: 16 September 2019; doi:10.1038/s41433-019-0568-y Oral medications for central serous chorioretinopathy: a literature review

  • 16 September 2019

Deep perifoveal vessel density as an indicator of capillary loss in high myopia – (Eye Journal)

Sep 16
2019

Eye, Published online: 16 September 2019; doi:10.1038/s41433-019-0573-1 Deep perifoveal vessel density as an indicator of capillary loss in high myopia

  • 16 September 2019

A FBN1 variant manifesting as non-syndromic ectopia lentis with retinal detachment: clinical and genetic characteristics – (Eye Journal)

Sep 16
2019

Eye, Published online: 16 September 2019; doi:10.1038/s41433-019-0580-2 A FBN1 variant manifesting as non-syndromic ectopia lentis with retinal detachment: clinical and genetic characteristics

  • 16 September 2019

Unwrapped hydroxyapatite orbital implants: our experience in 347 cases – (Eye Journal)

Sep 16
2019

Eye, Published online: 16 September 2019; doi:10.1038/s41433-019-0571-3 Unwrapped hydroxyapatite orbital implants: our experience in 347 cases

  • 16 September 2019